EUVIMEDEUVIMED entdecken
Editorial

Psychedelics as Therapeutics—Potential and Challenges

Nora D Volkow, Joshua A Gordon, Eric M Wargo

JAMA Psychiatry · 01.10.2023 · 80 (10) · 979

DOI: 10.1001/jamapsychiatry.2023.1968 ↗

Kurz gefasst

Editorial in der Zeitschrift JAMA Psychiatry, erschienen am 01.10.2023. Verfasst von Nora D Volkow und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Institute on Drug Abuse, Gaithersburg, Maryland. Hauptthemen laut MEDLINE: Hallucinogens, Mental Disorders. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint discusses the potential promise of the therapeutic use of psychedelics for mental illness and substance use disorders, acknowledging many open research questions and unique challenges with these substances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensMental DisordersHumans

Substanzen

Hallucinogens

Autor:innen und Institutionen

  • National Institute on Drug Abuse, Gaithersburg, Maryland.
  • National Institute of Mental Health, Bethesda, Maryland.

Zitieren

APA

Volkow, N. D., Gordon, J. A., & Wargo, E. M. (2023). Psychedelics as Therapeutics—Potential and Challenges. JAMA Psychiatry, 80(10), 979. https://doi.org/10.1001/jamapsychiatry.2023.1968

Vancouver

Volkow ND, Gordon JA, Wargo EM. Psychedelics as Therapeutics—Potential and Challenges. JAMA Psychiatry. 2023;80(10):979. doi:10.1001/jamapsychiatry.2023.1968

BibTeX
@article{Volkow2023,
  author = {Volkow, Nora D and Gordon, Joshua A and Wargo, Eric M},
  title = {Psychedelics as Therapeutics—Potential and Challenges},
  journal = {JAMA Psychiatry},
  year = {2023},
  volume = {80},
  number = {10},
  pages = {979},
  doi = {10.1001/jamapsychiatry.2023.1968}
}
Kostenlos starten →